India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
When followers overshadow morality Recently, a man known on social media as ‘Nepali Bro’ murdered his wife. This incident shocked everyone. Not thousands, but millions of people used to watch his content, react to his videos, and many saw him as an influential figure . But this incident has once again raised a serious question, ‘Are we making the mistake of considering the image we see on social media as the real person? What is the basis for us to know someone? His character, behavior and values or the popularity of his social media?’ He was a familiar face on social media. His videos used to go viral, people followed him, and his statements were quoted. But there is not always a correlation between a person’s popularity and his moral character . Social media shows us the edited, decorated and publicly displayed appearance of a person, but not his private life, behavior towards relationships, ability to control anger or human sensitivity. What is even more interesting is that...